SEC Form 4 · accession 0001535610-19-000053
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
SABBY MANAGEMENT, LLC
10% Owner
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 11:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 15, 2019 | P | 167,760 | $0.2351 | A | 1,043,408 | I | See Footnotes |
| Common StockF1,F2 | Jan 16, 2019 | P | 21,961 | $0.2703 | A | 1,065,369 | I | See Footnotes |
| Common StockF1,F2 | Jan 16, 2019 | P | 4,700 | $0.263 | A | 1,070,069 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor.
- F2The amounts reported herein reflect the entire amount of Issuer's common shares held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.